Cite Filings / IMVT
Feed Companies Filings Check
Sign in

CIK 0001764013 · Large accelerated filer

Immunovant, Inc.

Sign in to watch
Ticker
IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
832771572
Phone
917-410-3120
Business address
1000 PARK FORTY PLAZA, DURHAM, NC, 27713
Former names
Health Sciences Acquisitions Corp
Filings Insiders Search text
All 653 Financials 117 Shareholder Meetings 8 Executive Compensation 100 Insider Trading 360 Beneficial Ownership Interest 40 Business Combinations 88 Public Offerings 51 Mutual Funds and ETFs 7 Others 82
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-07-22
  3. DEF 14A Proxy Proxy Statement 2025-07-09
  4. DEF 14A Proxy Proxy Statement 2024-06-26
  5. DEF 14A Proxy Proxy Statement 2023-06-26
  6. DEF 14A Proxy Proxy Statement 2022-06-30
  7. DEF 14A Proxy Proxy Statement 2021-08-12
  8. PRE 14A Proxy Proxy Statement (Preliminary) 2021-08-02
  9. DEF 14A Proxy Proxy Statement 2020-07-09

Page 1 of 1 · 8 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…